Ocuphire Pharma | 8-K: Current report
Ocuphire Pharma | 8-K: Ocuphire Pharma Announces Financial Results for First Quarter 2024 and Provides Corporate Update
Ocuphire Pharma | DEF 14A: Definitive information statements
Ocuphire Pharma | DEFA14A: Others
Ocuphire Pharma | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Ocuphire Pharma | 8-K: Current report
Ocuphire Pharma | 8-K: Current report
Ocuphire Pharma | 8-K: Ocuphire Pharma Announces Financial Results for Fourth Quarter and Full Year 2023 and Provides Corporate Update
Ocuphire Pharma | 8-K: Current report
Ocuphire Pharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Ocuphire Pharma | S-3: Registration statement for specified transactions by certain issuers
Ocuphire Pharma | 8-K: Current report
Ocuphire Pharma | 8-K: Current report
Ocuphire Pharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Ocuphire Pharma | 8-K: Ocuphire Pharma Announces Financial Results for Third Quarter 2023 and Provides Corporate Update
Ocuphire Pharma | 8-K: Current report
Ocuphire Pharma | 8-K: Current report
Ocuphire Pharma | 8-K: Current report
Ocuphire Pharma | 8-K: Current report
Ocuphire Pharma | 8-K: Current report
No Data